- Home
- CELZ vs DRMA Comparison
CELZ vs DRMA Comparison
Compare CELZ & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELZ
- DRMA
- Stock Information
- Founded
- CELZ 1998
- DRMA 2014
- Country
- CELZ United States
- DRMA United States
- Employees
- CELZ N/A
- DRMA N/A
- Industry
- CELZ Biotechnology: Pharmaceutical Preparations
- DRMA Biotechnology: Pharmaceutical Preparations
- Sector
- CELZ Health Care
- DRMA Health Care
- Exchange
- CELZ Nasdaq
- DRMA Nasdaq
- Market Cap
- CELZ 5.5M
- DRMA 4.5M
- IPO Year
- CELZ N/A
- DRMA 2021
- Fundamental
- Price
- CELZ $2.02
- DRMA $0.79
- Analyst Decision
- CELZ
- DRMA Strong Buy
- Analyst Count
- CELZ 0
- DRMA 1
- Target Price
- CELZ N/A
- DRMA $6.00
- AVG Volume (30 Days)
- CELZ 34.9K
- DRMA 182.0K
- Earning Date
- CELZ 05-09-2025
- DRMA 05-14-2025
- Dividend Yield
- CELZ N/A
- DRMA N/A
- EPS Growth
- CELZ N/A
- DRMA N/A
- EPS
- CELZ N/A
- DRMA N/A
- Revenue
- CELZ $14,000.00
- DRMA N/A
- Revenue This Year
- CELZ N/A
- DRMA N/A
- Revenue Next Year
- CELZ N/A
- DRMA N/A
- P/E Ratio
- CELZ N/A
- DRMA N/A
- Revenue Growth
- CELZ 55.56
- DRMA N/A
- 52 Week Low
- CELZ $1.69
- DRMA $0.69
- 52 Week High
- CELZ $6.90
- DRMA $6.17
- Technical
- Relative Strength Index (RSI)
- CELZ 44.81
- DRMA 42.98
- Support Level
- CELZ $1.94
- DRMA $0.75
- Resistance Level
- CELZ $2.20
- DRMA $0.99
- Average True Range (ATR)
- CELZ 0.14
- DRMA 0.07
- MACD
- CELZ 0.04
- DRMA 0.01
- Stochastic Oscillator
- CELZ 40.00
- DRMA 23.46
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
About DRMA Dermata Therapeutics Inc.
Dermata Therapeutics Inc. is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to development and formulation of singular and combination products that can target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.